Bacillus Calmette-Guérin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004–2015

Bacillus Calmette-Guérin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004–2015

Mycobacterium bovis bacillus Calmette-Guérin (BCG) is used as a vaccine to protect against disseminated tuberculosis (TB) and as a treatment for bladder cancer. We describe characteristics of US TB patients reported to the National Tuberculosis Surveillance System (NTSS) whose disease was attributed...

Full description

Bibliographic Details
Main Authors: Zimy Wansaula, Jonathan M. Wortham, Godwin Mindra, Maryam B. Haddad, Jorge L. Salinas, David Ashkin, Sapna B. Morris, Gail B. Grant, Smita Ghosh, Adam J. Langer
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2019-03-01
Series:Emerging Infectious Diseases
Subjects:
Bacillus Calmette-Guérin
Mycobacterium bovis–BCG
tuberculosis
public health surveillance
TB
tuberculosis and other mycobacteria
Online Access:https://wwwnc.cdc.gov/eid/article/25/3/18-0686_article

Similar Items

Similar Items